Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Rapid Dose Therapeutics Corp ( (TSE:DOSE) ) is now available.
Rapid Dose Therapeutics has secured an Indian patent for its QuickStrip nicotine bilayer oral film, developed with Aavishkar Oral Strips, covering a controlled-release, fast-absorbing oral strip and its proprietary manufacturing process. The protection in India, a key consumer market and pharma manufacturing hub, marks a major step in the company’s global IP strategy and supports its push into the fast-growing smoke-free nicotine segment.
The company says the patent, together with broad PCT coverage across up to 158 jurisdictions and its joint ownership structure with Aavishkar, strengthens its negotiating leverage for commercial deals. Management highlighted that this milestone could advance ongoing discussions with a major global nicotine company, potentially enhancing Rapid Dose’s competitive position and value proposition for stakeholders in the expanding modern oral nicotine market.
The most recent analyst rating on (TSE:DOSE) stock is a Sell with a C$0.15 price target. To see the full list of analyst forecasts on Rapid Dose Therapeutics Corp stock, see the TSE:DOSE Stock Forecast page.
Spark’s Take on TSE:DOSE Stock
According to Spark, TipRanks’ AI Analyst, TSE:DOSE is a Neutral.
The score is primarily weighed down by weak financial performance (persistent large losses, negative equity, and ongoing cash burn). Technicals add caution with the stock trading below major moving averages and negative MACD, while valuation is difficult to justify with a negative P/E and no dividend yield data.
To see Spark’s full report on TSE:DOSE stock, click here.
More about Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company focused on oral thin film drug delivery technology. Its flagship QuickStrip platform uses fast-dissolving oral films to deliver active ingredients such as nicotine, pharmaceuticals, nutraceuticals and vaccines, targeting rapid onset and improved bioavailability across consumer and medical markets.
Average Trading Volume: 52,728
Technical Sentiment Signal: Sell
Current Market Cap: C$19.12M
Learn more about DOSE stock on TipRanks’ Stock Analysis page.